Namandjé Bumpus
American pharmacologist / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Namandjé Bumpus?
Summarize this article for a 10 year old
Namandjé N. Bumpus is an American pharmacologist who serves as the Principal Deputy Commissioner and Acting Chief Scientist of the Food and Drug Administration.[2] She was previously director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, where she holds the E.K. Marshall and Thomas H. Maren professorship in pharmacology.[5][2] Bumpus is known for her research on the metabolism of antiviral drugs used to treat HIV-1 and how genetic variations in drug-processing enzymes may impact these drugs' efficacy.[6] Bumpus received a Presidential Early Career Award for Scientists and Engineers in 2016.[7] The Food and Drug Administration’s top scientist Namandjé Bumpus has assumed the role of principal deputy commissioner when longtime agency leader Janet Woodcock retired from that role in January 2024.
Namandjé Bumpus | |
---|---|
Born | (1981-02-07) February 7, 1981 (age 43)[citation needed] |
Alma mater | Occidental College (B.A. 2003)[1] University of Michigan (Ph.D. 2007)[2][3] |
Known for | research on cytochrome P450s, antiviral drug metabolism |
Awards | Presidential Early Career Award for Scientists and Engineers John J. Abel Award |
Scientific career | |
Fields | pharmacology; drug metabolism; toxicology; pharmacogenetics; pharmacokinetics |
Institutions | Johns Hopkins University School of Medicine |
Doctoral advisor | Paul F. Hollenberg[4] |